UW-Stout PreCollege 2012: Science


UW-Stout PreCollege 2012: Science Sustainability
University of Wisconsin-Stout PreCollege Summer 2012 Science Sustainability July 8-14, 2012 Students explore applied science as it relates to the world and environment. Students gain insight on how biology, ecology and chemistry are a huge part in soving issues of today and give us hope for tomorrow Video by Kalvin Chue Yang Nou Chee HerFrom:stoutmssViews:0 0ratingsTime:03:43More inEducation

Original post:
UW-Stout PreCollege 2012: Science

Bioscience PhD Overview Video – Video


Bioscience PhD Overview Video
Bioscience PhD Programs The Bioscience PhD Programs provides a cross-diciplinary, collaborative training environment that enables students to experience a wide-ranging selection of research opportunities representing nine departments at the University of Utah. The program houses the Molecular Biology and Biological Chemistry programs. Each program is distinct in its core curriculum and requirements (Program Comparison). The programs allow students to experience a broad scientific education, yet tailor their training to their specific interests. Students will participate in cutting-edge research mentored by world-class scientists. In addition, the programs provide the thorough training necessary to become a creative and analytical thinker essential of a successful career in science.From:UofUBiosciencePhDViews:1 0ratingsTime:02:22More inEducation

See original here:
Bioscience PhD Overview Video - Video

Chill Edit – #26 | Thought v2 – Video


Chill Edit - #26 | Thought v2
#10004;Thumbs up Favorite for an awesome sequel to #39;Thought #39; #9658;PREVIOUS Chiill Edit (Thought v1): tinyurl.com #9755;LIKE on: http://www.facebook.com #9733;TOP 150 Edits: tinyurl.com #9688;SHARE this video! Creator: http://www.youtube.com About Thought: (You can get smart and pick up girls by watching KC) Thought generally refers to any mental or intellectual activity involving an individual #39;s subjective consciousness. It can refer either to the act of thinking or the resulting ideas or arrangements of ideas. Similar concepts include cognition, sentience, consciousness, and imagination.[1] Because thought underlies almost all human actions and interactions, understanding its physical and metaphysical origins, processes, and effects has been a longstanding goal of many academic disciplines including, among others, biology, philosophy, psychology, and sociology. Thinking allows beings to make sense of or model the world in different ways, and to represent or interpret it in ways that are significant to them, or which accord with their needs, attachments, objectives, plans, commitments, ends and desires. -------------------------------------------------------- Watch the latest episodes of the best Series! Overedit Show: tinyurl.com Sexy Edit Show: tinyurl.com Chill Edit Show: tinyurl.com Check out our YouTube playlists! Edits: tinyurl.com Real Life Edits: tinyurl.com Montages: tinyurl.com Ad Free Videos! tinyurl.com Comedy: tinyurl.com Trailers: tinyurl.com Promos: tinyurl.com Commentary #39;s: tinyurl.com ...From:KuantumCinemaViews:25 3ratingsTime:00:36More inShows

Here is the original post:
Chill Edit - #26 | Thought v2 - Video

Thought by thundR – Video


Thought by thundR
Editor - http://www.youtube.com Song - (Loading...) About Thought- Thought generally refers to any mental or intellectual activity involving an individual #39;s subjective consciousness. It can refer either to the act of thinking or the resulting ideas or arrangements of ideas. Similar concepts include cognition, sentience, consciousness, and imagination.[1] Because thought underlies almost all human actions and interactions, understanding its physical and metaphysical origins, processes, and effects has been a longstanding goal of many academic disciplines including, among others, biology, philosophy, psychology, and sociology. Thinking allows beings to make sense of or model the world in different ways, and to represent or interpret it in ways that are significant to them, or which accord with their needs, attachments, objectives, plans, commitments, ends and desires. ---------------------------------------- ----------------From:MassiveEditingViews:0 0ratingsTime:00:45More inFilm Animation

View post:
Thought by thundR - Video

Building Medical Robots, Bacteria sized: Bradley Nelson at TEDxZurich – Video


Building Medical Robots, Bacteria sized: Bradley Nelson at TEDxZurich
We learned of the existence of bacteria over 300 years ago and we have far more of them in our bodies than human cells, but it was less than 40 years ago when we first realized how they swim. With the discovery of the rotary motor of E. coli in 1973, a motor just 45 nanometers in diameter, some claimed this incredible mechanism as evidence of God, though it is really just a step along the path of evolution. Now we can actually build nanorobots that swim similar to bacteria like E. coli. We #39;re working to use these to deliver drugs to specific locations in the body. E. coli itself is a kind of robot: it has sensors (chemoreceptors), motors, communication along protein guided pathways, and software (DNA). When we look at a bacterium from this perspective it seems like a machine, even one that we will be hopefully able to duplicate someday. So if bacteria are really just machines then what are we? Brad Nelson is the Professor of Robotics and Intelligent Systems at ETH Zürich where his primary research focus is on microrobotics and nanorobotics with an emphasis on applications in biology and medicine. He studied mechanical engineering at the University of Illinois at Urbana-Champaign and the University of Minnesota and robotics at Carnegie Mellon University. He has worked at Honeywell and Motorola and served as a United States Peace Corps Volunteer in Botswana, Africa. He was a professor at the University of Illiois at Chicago and the University of Minnesota before joining ETH ...From:TEDxTalksViews:0 0ratingsTime:14:03More inEducation

Visit link:
Building Medical Robots, Bacteria sized: Bradley Nelson at TEDxZurich - Video

Under The Flea – Video


Under The Flea
Filmed off the coast of California in an underground catnip deposit, the discovery of two specifically significant specimens is set to capsize the field Marine Biology. This pair of illustrious sea creatures are some of the largest ever to explore the depths of Earth #39;s oceans and science has finally managed to capture both of them in a single shot. The wild Catback Whale and the elusive Fat Fish are rare specimens indeed as most seekers of these sea demons, including those who have devoted their entire careers to such efforts, would be considered lucky to catch a single cockeyed glimpse in an entire lifetime. As such, no official sightings have ever been reported and most facts and figures of these large mammals has relied heavily on folklore and stories passed down through generations. What does it take to finally capture such an unpredictable beast? Timing, opportunity, lucky, and, above all else, a little dream dust.From:OptimusBenignViews:1 0ratingsTime:00:41More inPets Animals

Link:
Under The Flea - Video

Mmolecular mechanisms leading to basal cell carcinoma initiation uncovered

ScienceDaily (Nov. 26, 2012) One of the most outstanding and unresolved questions in cancer biology is the identification of cells at the origin of cancer and the understanding of the molecular changes that occur in tumor initiating cells from the first oncogenic mutation to the development of invasive cancer. Basal cell carcinoma (BCC) is the most frequent cancer in human with more than million of new patients diagnosed each year with BCCs.

Recently, the group of Pr. Cdric Blanpain uncovered the cells at the origin of BCC (Youssef et al, Nature Cell Biology, 2010).

In a new study published in advanced online publication of Nature Cell Biology, researchers lead by Cdric Blanpain, MD/PhD, Professor at Universit libre de Bruxelles (ULB) and WELBIO investigator dissected for the first time the molecular changes occurring in basal cell carcinoma initiating cells from the first oncogenic mutation until the development of invasive cancer.

Khalil Kass Youssef and colleagues established the molecular signature of tumor initiating cells at different time during cancer initiation. They found that that cells at the origin of the basal cell carcinoma were progressively reprogrammed into embryonic hair follicle progenitor like fate before progressing into invasive carcinoma. "We were extremely surprised to see that tumor initiating cells were progressively and profoundly reprogram into a molecular identity that resemble to progenitor cells presented during embryonic development" comments Khalil Kass Youssef, the first author of this study.

In collaboration with bioinformaticians from the ULB and the KUL, the researchers demonstrate that Wnt/-catenin signaling pathway is activated in BCC-initiating cells soon after oncogene expression. Using genetic or pharmacologic inhibition of the Wnt/-catenin signaling, the researchers demonstrate that Wnt/beta-catenin signaling is essential for the reprograming of tumor initiating cells into embryonic hair follicle progenitors and for tumor initiation.

In collaboration with physicians from the Department of Dermatology, Pathology and Plastic Surgery from the Hospital Erasme, the group of Cdric Blanpain demonstrate that human BCCs also present signs of reprograming into embryonic hair follicle progenitors and activation of the Wnt/beta-catenin signaling, demonstrating the relevance of these findings for human patients.

This new work is at the frontier of multiple fields of biology and medicine and will be extremely important for researchers studying cancer, development, and stem cell biology. "I am particularly excited about this work, because this basic research turn out to be very relevant for human diseases, with the identification of potentially new avenues to treat or to prevent the occurrence of the most common cancer in humans " comments Pr Cdric Blanpain.

This work was supported by the FNRS, the program d'excellence CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer, the Fondation ULB, the Fond Yvonne Bol, the Fond Gaston Ithier, a starting grant of the European Research Council (ERC) and the EMBO Young Investigator Program.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

Follow this link:
Mmolecular mechanisms leading to basal cell carcinoma initiation uncovered

DGAP-News: Evotec enters biology collaboration with Probiodrug

Hamburg, Germany - 28 November 2012: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) announced today that it has entered into a collaboration with Probiodrug AG, a privately owned biopharmaceutical company focused on the development of innovative drugs for the treatment of major age related diseases.

Under the terms of the agreement, Evotec will setup and validate assays to support the pre-clinical and clinical development of glutaminyl cyclase (QC) inhibitors for the treatment of Alzheimers disease. Glutaminyl cyclase is a novel proprietary enzyme target discovered and validated by Probiodrug which plays a crucial role in the pathogenesis of Alzheimers disease (AD) as well as potentially other diseases.

Dr Mario Polywka, Chief Operating Officer of Evotec commented: We are pleased to enter this collaboration with Probiodrug to use our first class assay development capabilities to support the pre-clinical and clinical development of QC inhibitors in Alzheimers disease and other indications. This is a good example of how Evotec can support Biotech companies with their specific drug discovery needs.

Hendrik Liebers, Chief Financial Officer of Probiodrug, added: The collaboration will allow us to focus on the further pre-clinical and clinical development of our programmes in neurodegeneration/AD. Evotec, with its proven track record, is ideally suited to accompany this process by running existing and developing new biological assays.

ABOUT PROBIODRUG AG Probiodrug is a biopharmaceutical company dedicated to the discovery and development of small molecule drugs against novel molecular targets for the treatment of neuronal and inflammatory diseases. The Company has a dominant position in the area of glutaminyl cyclase inhibition. Glutaminyl cyclase, a novel enzyme target discovered and patented by Probiodrug, has a crucial role in the pathogenesis of Alzheimers disease (AD) as well as various peripheral inflammatory diseases. Probiodrug is backed by institutions such as BB Biotech, Edmond de Rothschild Investment Partners, Goodvent/IBG, HBM, TVM, Life Sciences Partners, Biogen Idec Ventures, CFH Group, funds managed by Wellington Management, and private investors. Probiodrugs core capabilities are based on its long-standing expertise in the elucidation of the structure and function of enzymes which play a central role in the maturation of hormones. The Company has pioneered the field of dipeptidyl peptidase 4 (DP4)-inhibition for the treatment of type 2 diabetes. Compounds and technology patents of its DP4 program in diabetes were licensed to various pharmaceutical companies. In 2004, all metabolic assets were sold to OSI Pharmaceuticals, Inc. The first drug based on Probiodrugs technologies reached the market in late 2006. Proceeds of the various transactions have been reinvested by the Company to fund the novel approach for the treatment of AD and inflammatory diseases. The Company was founded in 1997 by Prof Dr Hans-Ulrich Demuth and Dr Konrad Glund. Probiodrug has raised EUR71 m for its QC program. For more information please visit http://www.probiodrug.de.

FORWARD LOOKING STATEMENTS - Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this report. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.

Contact Evotec AG: Dr Mario Polywka, Chief Operating Officer, Phone: +44.(0)1235.441676, [emailprotected]

End of Corporate News

See the original post here:
DGAP-News: Evotec enters biology collaboration with Probiodrug

Scientists at the Institute of Molecular Biology identify key event for sex determination

Public release date: 27-Nov-2012 [ | E-mail | Share ]

Contact: Ralf Dahm press@imb-mainz.de 49-613-139-21455 Johannes Gutenberg Universitaet Mainz

Scientists at the Institute of Molecular Biology (IMB) in Mainz have identified a protein essential for initiating the development of male sex organs. Loss of the gene Gadd45g results in complete sex reversal of male mice, making them appear female. The researchers' finding uncovers a novel signaling cascade, which acts early in development to determine the gonads in males. This discovery sheds light on the genetic network that controls how embryos develop as males or females. The research has just been published in the high-impact journal Developmental Cell.

Research carried out in the laboratory of IMB Director Professor Christof Niehrs uncovered that the deletion of just one gene, Gadd45g, results in male mice with external genitalia that are indistinguishable from those of female mice. Furthermore, the internal reproductive organs of the mutant male mice look like those of females, indicating that a complete sex reversal has occurred. Says Christof Niehrs, "when breeding Gadd45g mutant mice we were puzzled why we got only females, until we discovered that some of these females actually carry a Y-chromosome."

The researchers further showed that Gadd45g exerts its effect by regulating signaling cascades that control the gene Sry, which had previously shown to be a master regulator of male sex development. This study both identifies a new role for Gadd45g and suggests a novel signaling pathway that could have important implications for research into disorders of sexual development.

For male sex organs to develop correctly, it is essential that the gene Sry is expressed at high levels within a very narrow timeframe in the embryo. The group of Christof Niehrs has now shown that Gadd45g is expressed in a pattern highly similar to that of Sry. The Gadd45g gene is, however, active just before Sry is turned on. Importantly, in mice lacking Gadd45g, the Sry gene is not expressed correctly. This indicates that Gadd45g controls the expression of this master regulator and, in turn, male development.

The scientists also provide a possible mechanism by which Gadd45g regulates Sry. Their model suggests that Gadd45g binds to and activates key signaling proteins, such as p38, which activate the transcription factor Gata4. When active, this factor binds to and activates the Sry gene. Similar results are co-published in the same issue of Developmental Cell by the group of Andy Greenfield in the UK. "As outsiders to the field of sex determination we were surprised by how little was known about the regulation of Sry on the molecular level. Our work is a leap forward in the understanding of this fundamental process", says Niehrs.

###

Original reference: Mathias S Gierl, Wolfram H Gruhn, Annika von Seggern, Nicole Maltry and Christof Niehrs (2012). Gadd45g functions in male sex determination by promoting p38 signaling and Sry expression. Developmental Cell 23(5):1032-42

INSTITUTE OF MOLECULAR BIOLOGY gGmbH (IMB)

Continued here:
Scientists at the Institute of Molecular Biology identify key event for sex determination

Evotec Enters Biology Collaboration With Probiodrug

HAMBURG, Germany, Nov. 28, 2012 (GLOBE NEWSWIRE) -- Evotec AG (EVT.F) (TecDAX) announced today that it has entered into a collaboration with Probiodrug AG, a privately owned biopharmaceutical company focused on the development of innovative drugs for the treatment of major age related diseases.

Under the terms of the agreement, Evotec will setup and validate assays to support the pre-clinical and clinical development of glutaminyl cyclase (QC) inhibitors for the treatment of Alzheimer's disease. Glutaminyl cyclase is a novel proprietary enzyme target discovered and validated by Probiodrug which plays a crucial role in the pathogenesis of Alzheimer's disease (AD) as well as potentially other diseases.

Dr Mario Polywka, Chief Operating Officer of Evotec commented: "We are pleased to enter this collaboration with Probiodrug to use our first class assay development capabilities to support the pre-clinical and clinical development of QC inhibitors in Alzheimer's disease and other indications. This is a good example of how Evotec can support Biotech companies with their specific drug discovery needs."

Hendrik Liebers, Chief Financial Officer of Probiodrug, added: "The collaboration will allow us to focus on the further pre-clinical and clinical development of our programmes in neurodegeneration/AD. Evotec, with its proven track record, is ideally suited to accompany this process by running existing and developing new biological assays."

ABOUT PROBIODRUG AG

Probiodrug is a biopharmaceutical company dedicated to the discovery and development of small molecule drugs against novel molecular targets for the treatment of neuronal and inflammatory diseases. The Company has a dominant position in the area of glutaminyl cyclase inhibition. Glutaminyl cyclase, a novel enzyme target discovered and patented by Probiodrug, has a crucial role in the pathogenesis of Alzheimer's disease (AD) as well as various peripheral inflammatory diseases.

Probiodrug is backed by institutions such as BB Biotech, Edmond de Rothschild Investment Partners, Goodvent/IBG, HBM, TVM, Life Sciences Partners, Biogen Idec Ventures, CFH Group, funds managed by Wellington Management, and private investors.

Probiodrug's core capabilities are based on its long-standing expertise in the elucidation of the structure and function of enzymes which play a central role in the maturation of hormones. The Company has pioneered the field of dipeptidyl peptidase 4 (DP4)-inhibition for the treatment of type 2 diabetes. Compounds and technology patents of its DP4 program in diabetes were licensed to various pharmaceutical companies. In 2004, all metabolic assets were sold to OSI Pharmaceuticals, Inc. The first drug based on Probiodrug's technologies reached the market in late 2006. Proceeds of the various transactions have been reinvested by the Company to fund the novel approach for the treatment of AD and inflammatory diseases.

The Company was founded in 1997 by Prof Dr Hans-Ulrich Demuth and Dr Konrad Glund. Probiodrug has raised EUR71 m for its QC program. For more information please visit http://www.probiodrug.de.

ABOUT EVOTEC AG

Excerpt from:
Evotec Enters Biology Collaboration With Probiodrug

Chesterfield Learning Center Video | Tutoring Services in Midlothian – Video


Chesterfield Learning Center Video | Tutoring Services in Midlothian
http://www.chesterfieldlearningcenter.com At Chesterfield Learning Center we help struggling students close the gap between their current skills and what is expected in the classroom through one-on-one instruction using state-of-the art, research-based educational methods. At Chesterfield Learning Center, your child is cared for as one of our own. We reflect our commitment through the following core values Dedication, Honesty, Equality, Respect, Collaboration 12550222 Tutoring, Elementary School, Middle School, High School, Reading Improvement, College Preparation, Special Needs, Adult Tutoring, Test Preparation, SAT, ACT, Math, Geometry, Calculus, Statistics, Science, Biology, Social Studies, Foreign Language, PSAT, GED, GRE, SSAT, GMAT Virginia, WWBTFrom:DataSphereVideosViews:1 0ratingsTime:01:14More inPeople Blogs

See the rest here:
Chesterfield Learning Center Video | Tutoring Services in Midlothian - Video

How random is social behaviour? – Video


How random is social behaviour?
Stochastic simulation of the spatial dynamics of a population of wild house mice across their perceptual landscape. Supplemental video to the paper: Perony N., Tessone, CJ, König, B., and Schweitzer, F.: How Random Is Social Behaviour? Disentangling Social Complexity through the Study of a Wild House Mouse Population, PLoS Computational Biology (2012). dx.doi.orgFrom:Nicolas PeronyViews:45 0ratingsTime:01:22More inPeople Blogs

Read this article:
How random is social behaviour? - Video